Regulatory T cells dictate immunity during persistent Salmonella infection
调节性 T 细胞在持续沙门氏菌感染期间决定免疫力
基本信息
- 批准号:7990602
- 负责人:
- 金额:$ 36.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAffinityAntibioticsBacterial InfectionsCD4 Positive T LymphocytesCellsDefectDevelopmentEquilibriumGoalsGranzymeHost DefenseHumanHuman CharacteristicsImmuneImmune ToleranceImmunityImmunosuppressionIn VitroInfectionInfection ControlInjuryInterleukin-10KineticsKnowledgeLigandsMediatingModelingMolecularMusOutcomePathogenesisPatternPattern recognition receptorPeripheralPlayPredispositionReagentRegulatory T-LymphocyteRelative (related person)ReporterResearchRiskRoleSalmonellaSalmonella infectionsSalmonella paratyphiSalmonella typhiSalmonella typhimuriumSignal TransductionT-Cell ActivationT-LymphocyteTechniquesTimeTissuesTyphoid FeverWorkbasediphtheria toxin receptorimmune activationmicrobialmouse modelpathogenperipheral toleranceprogramspublic health relevancereceptorreconstitutionresearch studytool
项目摘要
DESCRIPTION (provided by applicant): Typhoid fever is a persistent infection caused by host adapted Salmonella species. Paradoxically, allowing pathogen persistence may also be beneficial for the host when immune-mediated damage outweigh the immediate risk posed by the infection. Our long-term goals are to identify the immune cells and signals activated during Salmonella infection that controls this balance between immune activation required for pathogen eradication with the associated risk of immune-mediated host injury, and immune suppression at the expense of pathogen persistence. The mouse model of S. typhimurium infection reproduces important features of persistent infection characteristic of human typhoid. Together with the abundance of immunological tools and reagents available only in mice, infection in this species is currently the best-available model for identifying the molecular and cellular signals that control this delicate immunological balance. Using this model, our preliminary studies indicate regulatory T cells (Tregs) that comprise a distinct lineage of CD4+ T cells characterized by Foxp3-expression play critical roles in dictating the balance between immune activation and bacterial persistence. Early after infection, Foxp3+Treg-ablation accelerates the kinetics of bacterial eradication, while augmenting Foxp3+Tregs causes reciprocal increases in pathogen burden. Therefore the overall goals of this application are to define the relative importance and identify the suppressive mechanism utilized by Tregs throughout persistent Salmonella infection. Aim 1 will expand on our preliminary findings that demonstrate drastic changes in Treg suppressive potency for cells isolated at early (day 5) and late (day 37) time points, by defining a comprehensive kinetic analysis for changes in Treg suppressive potency during persistent infection. Our specific goals are to identify when Treg suppressive potency peaks, nadirs, and returns to baseline levels, and the absolute magnitude for these changes. These results will establish the frame-work for complementary experiments that verify the importance of Tregs at these critical time points by quantifying the relative impacts of Treg-ablation. Using recently developed techniques for reconstituting Treg- ablated mice with donor Tregs from mice with targeted defects in defined Treg-associated molecules, Aim 2 will further explore the mechanistic basis for these changes in Treg suppression potency. These include experiments that will identify and dissociate the specific Treg-associated molecules that control host defense from those required for sustaining peripheral immune tolerance, and define Salmonella ligands and the corresponding pattern recognition receptors that dictate these changes in Treg suppression potency through cell-intrinsic stimulation. Together these experiments that utilize cutting edge immunological tools will not only fill important gaps in our current knowledge on the importance and the mechanism whereby Foxp3+Tregs control host defense during Salmonella infection, but also establish important paradigms for how Tregs may regulate immunity during other persistent infections.
PUBLIC HEALTH RELEVANCE: The pathogenesis of persistent infection is controlled by the balance between opposing immune activation and suppression signals. Using Salmonella infection in mice as a model of human typhoid, this application seeks to define the importance of regulatory T cells, and identify the molecular basis whereby these cells control this delicate immunological balance during persistent bacterial infection.
描述(由申请人提供):伤寒是一种由宿主适应沙门氏菌引起的持续性感染。矛盾的是,当免疫介导的损伤超过感染造成的直接风险时,允许病原体持续存在也可能对宿主有益。我们的长期目标是确定沙门氏菌感染期间激活的免疫细胞和信号,这些免疫细胞和信号控制着病原体根除所需的免疫激活与相关免疫介导宿主损伤风险之间的平衡,以及以病原体持久性为代价的免疫抑制。鼠伤寒沙门氏菌感染小鼠模型再现了人类伤寒持续感染的重要特征。再加上丰富的免疫工具和试剂仅在小鼠中可用,这种物种的感染目前是识别控制这种微妙免疫平衡的分子和细胞信号的最佳可用模型。使用该模型,我们的初步研究表明,由foxp3表达特征的CD4+ T细胞的不同谱系组成的调节性T细胞(Tregs)在决定免疫激活和细菌持久性之间的平衡方面发挥关键作用。感染后早期,Foxp3+ treg消融加速了细菌根除动力学,而Foxp3+ treg增加则导致病原体负担的相互增加。因此,本应用程序的总体目标是确定Tregs在持续沙门氏菌感染过程中的相对重要性并确定其抑制机制。Aim 1将扩展我们的初步发现,通过定义持续感染期间Treg抑制效力变化的综合动力学分析,证明在早期(第5天)和晚期(第37天)时间点分离的细胞中Treg抑制效力发生了剧烈变化。我们的具体目标是确定Treg抑制效力何时达到峰值、最低点和恢复到基线水平,以及这些变化的绝对幅度。这些结果将为补充实验建立框架,通过量化treg消融的相对影响,验证treg在这些关键时间点的重要性。利用最近开发的技术,利用具有Treg相关分子靶向缺陷的小鼠的供体Treg重建Treg消融小鼠,Aim 2将进一步探索这些Treg抑制效能变化的机制基础。这些实验将识别和分离控制宿主防御的特定Treg相关分子和维持外周免疫耐受所需的分子,并定义沙门氏菌配体和相应的模式识别受体,这些受体通过细胞内在刺激指示Treg抑制效能的这些变化。这些利用尖端免疫学工具的实验不仅将填补我们目前在沙门氏菌感染期间Foxp3+Tregs控制宿主防御的重要性和机制方面的重要空白,而且还将为Tregs在其他持续性感染期间如何调节免疫建立重要的范式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sing Sing Way其他文献
Sing Sing Way的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sing Sing Way', 18)}}的其他基金
Kruppel-like factor-2 CD4+ T cells and intestinal inflammation
Kruppel 样因子 2 CD4 T 细胞和肠道炎症
- 批准号:
10730990 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Progesterone induced immune modulation during pregnancy – supplemental research in COVID-19
怀孕期间黄体酮诱导的免疫调节 — COVID-19 的补充研究
- 批准号:
10200397 - 财政年份:2021
- 资助金额:
$ 36.88万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
9797361 - 财政年份:2019
- 资助金额:
$ 36.88万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10625933 - 财政年份:2019
- 资助金额:
$ 36.88万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10441395 - 财政年份:2019
- 资助金额:
$ 36.88万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10192641 - 财政年份:2019
- 资助金额:
$ 36.88万 - 项目类别:
Progesterone induced immune modulation during pregnancy
怀孕期间黄体酮诱导的免疫调节
- 批准号:
10653014 - 财政年份:2019
- 资助金额:
$ 36.88万 - 项目类别:
Progesterone induced immune modulation during pregnancy – supplemental research in COVID-19
怀孕期间黄体酮诱导的免疫调节 — COVID-19 的补充研究
- 批准号:
10344851 - 财政年份:2019
- 资助金额:
$ 36.88万 - 项目类别:
Systemic immune modulation by enteric commensal fungi
肠道共生真菌的系统免疫调节
- 批准号:
9066379 - 财政年份:2016
- 资助金额:
$ 36.88万 - 项目类别:
Immunological identity redefined by genetically foreign microchimeric cells
外源微嵌合细胞重新定义免疫学特性
- 批准号:
9339521 - 财政年份:2016
- 资助金额:
$ 36.88万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 36.88万 - 项目类别:
Continuing Grant